VCTE vs. histology in MASLD

The study included 3,532 adults with MASLD.

Share

1

VCTE-based liver stiffness measurement (LSM) predicts liver-related outcomes in MASLD with accuracy comparable to liver biopsy.
2

The study analyzed 3,532 adults with MASLD, all of whom underwent both VCTE and liver biopsy at baseline.
3

During a median follow-up of 56.6 months, 126 patients (3.6%) developed liver-related events, primarily due to hepatic decompensation.
4

Five-year AUROC values for LSM and histology were nearly identical at 0.870 and 0.869, respectively.
5

LSM may serve as a practical alternative to histology for prognostic endpoints in clinical trials and risk stratification.